Ikris Pharma
About Us Named Patient Program
Cities We Serve Contact Us
Zemdri

Sourced directly from the authorized manufacturer network to ensure authenticity and quality.

Ready to proceed? Start a request for Zemdri on our secure patient portal to submit your prescription, upload documents and track your approval status.

Zemdri

Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.

Medicine Name: Zemdri
Generic Name (API): Plazomicin
Dosage Form & Strength: 500 mg / 10 ml
Route: Intravenous Infusion
Drug Class:

Manufacturer / Innovator:

Cipla USA Inc.

Regulatory Approval:

  • FDA (US) – discontinued
Family enjoying life with Named Patient Program access

Your Trustworthy Partner For Named Patient Program

  • your trusted partner for named patient program

    Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.

  • 100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

    100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.

  • Medicines sourced from authorized manufacturers with full batch traceability

    Medicines sourced from authorized manufacturers with full batch traceability.

  • EU-GDP Compliant Warehousing for secure, quality-controlled global distribution.

    EU-GDP compliant warehousing for secure, quality-controlled global distribution.

  • Temperature-Controlled Logistics for Safe and Timely Delivery

    Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.

GDP Compliant View Certificate
Licensed Wholesale distributor View Certificate

Understanding Zemdri and Its Medical Uses

Zemdri (plazomicin) is an aminoglycoside antibacterial approved by the FDA for the treatment of adults 18 years and older with complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible strains of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae.

How Zemdri Works

Zemdri is a next-generation aminoglycoside that inhibits bacterial protein synthesis, and has been specifically engineered to retain activity against many bacteria that have developed resistance to older aminoglycosides through common resistance mechanisms.

Approved Patient Population

Zemdri is intended for adult patients with complicated urinary tract infections, including kidney infections (pyelonephritis), caused by susceptible Gram-negative bacteria, particularly relevant in settings with rising antibiotic resistance.

Dosage and Administration

The recommended dose of Zemdri for patients with normal renal function (CrCl 90 mL/min or greater) is 15 mg/kg administered intravenously once every 24 hours over 30 minutes, for 4 to 7 days total duration, with dose adjustments required for renal impairment.

Warnings and Precautions for Zemdri

Boxed Warning — Zemdri: Zemdri carries risks of nephrotoxicity, ototoxicity, neuromuscular blockade, and fetal harm. Nephrotoxicity risk is greater in patients with impaired renal function, the elderly, and those receiving concomitant nephrotoxic drugs. Ototoxicity, including irreversible hearing loss and vestibular toxicity, can occur. Neuromuscular blockade and respiratory paralysis can occur, particularly with concurrent use of anesthetics or neuromuscular blocking agents. Zemdri can cause fetal harm when administered to a pregnant woman.

Kidney Function Monitoring

Renal function should be assessed before and during treatment, with dose adjustment based on creatinine clearance.

Hearing and Balance Monitoring

Patients should be monitored for signs of hearing loss, tinnitus, or vertigo, particularly with prolonged use or in patients with pre-existing risk factors.

Hypersensitivity and C. difficile Diarrhea

Hypersensitivity reactions and Clostridioides difficile-associated diarrhea have been reported, as with other antibacterial agents.

How to Access Zemdri in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation and Availability of Zemdri

Zemdri is manufactured and marketed by Cipla USA Inc. It is sourced through authorized distribution channels for patients seeking named-patient import into India.

Required Documentation

Patients typically need a valid prescription from a treating infectious disease specialist or urologist confirming complicated UTI diagnosis and susceptibility testing where available. NPP's regulatory team assists in preparing and verifying the documentation needed for a compliant import.

Availability

As an FDA-approved therapy for complicated urinary tract infections, Zemdri is sourced through authorized channels and imported under GDP-compliant, cold-chain logistics to preserve product quality throughout transit.

Sourcing and Delivery of Zemdri

NPP sources Zemdri directly from authorized pharmaceutical distributors to ensure product authenticity and full traceability. Every shipment is handled under Good Distribution Practice (GDP) conditions from origin to the patient's doorstep.

Cold Chain and Handling

Zemdri requires refrigerated storage at 2°C to 8°C. NPP maintains a continuous, monitored cold chain throughout transit.

Delivery Timelines

Once documentation and regulatory approvals are in place, delivery timelines are communicated transparently at the time of quotation, accounting for import clearance and last-mile cold-chain logistics to the patient's city.

Availability of Zemdri Across Major Cities in India

Patients across India can access Zemdri through NPP's regulated import pathway, with infectious disease specialists in major cities supporting the treatment process.

Mumbai

Leading hospitals in Mumbai support infectious disease and urology care coordination and documentation for Zemdri access.

Delhi

Delhi's major hospitals assist patients with prescription support and documentation for Zemdri.

Bangalore

Bangalore's specialist network offers access coordination for eligible patients seeking Zemdri.

Chennai

Chennai-based infectious disease specialists coordinate Zemdri access alongside comprehensive UTI care.

Hyderabad

Hyderabad's care institutions support patients pursuing Zemdri therapy.

Kolkata

Kolkata's specialist centers help coordinate documentation and treatment access for Zemdri.

Pune

Pune-based specialists assist with prescription support and Zemdri treatment planning.

Ahmedabad

Ahmedabad's specialty hospitals support the import and treatment process for Zemdri.

Kochi

Kochi's specialist units assist patients with the documentation needed for Zemdri access.

Chandigarh

Chandigarh's care centers support Zemdri treatment coordination for patients from North India.

Jaipur

Jaipur's specialists help patients navigate the Zemdri access process.

Lucknow

Lucknow-based centers assist patients pursuing Zemdri therapy.

Bhubaneswar

Bhubaneswar's institutions support access to Zemdri for eligible patients.

Guwahati

Guwahati's specialists help coordinate Zemdri access for patients across the Northeast.

Patients in other cities across India can also access Zemdri through NPP's nationwide coordination network.

Author Details

Nitin Goswami

Written By

Nitin Goswami

Deputy Manager – Content & Social Media, Ikris Pharma Network

Sources: FDA

Dr. Chirag C Shah

Medically Reviewed By

Dr. Chirag C Shah

MBBS

Last Updated: 15 September 2026

More Other Therapeutic Areas Medicines

TRUSTED BY HEALTHCARE PROFESSIONALS & HOSPITALS

Need Help
Accessing Medicines?

Our specialists are here to guide you through every step of the medicine access process.

Let's us help!

Send us a message

Read how to access medicines

Read More arrow icon

Frequently Asked
Questions

Read More
Meet the NPP Assistant: ask us anything about NPP